Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Dec 30;11(12):e0168974.
doi: 10.1371/journal.pone.0168974. eCollection 2016.

Effects of Feeding Milk Replacer Ad Libitum or in Restricted Amounts for the First Five Weeks of Life on the Growth, Metabolic Adaptation, and Immune Status of Newborn Calves

Affiliations

Effects of Feeding Milk Replacer Ad Libitum or in Restricted Amounts for the First Five Weeks of Life on the Growth, Metabolic Adaptation, and Immune Status of Newborn Calves

Christine T Schäff et al. PLoS One. .

Abstract

The pre-weaning period is critical for calf health and growth, and intensive milk feeding programs may assist postnatal development by improving body growth and organ maturation. The aim of the present work was to study the effects of ad libitum milk replacer (MR) feeding on the growth, metabolic adaptation, health, and immune status of newborn calves. Twenty-eight newborn Holstein and Holstein x Charolais crossbred calves were fed ad libitum (ADLIB) or in restricted amounts (6 liters per day; RES) during the first five weeks of life. The MR intake in the ADLIB treatment was gradually reduced at weeks 6 and 7, and all calves then received 6 liters of MR per day until day 60. Blood samples were collected to measure the plasma concentrations of metabolites, insulin, insulin-like growth factor (IGF)-I and IGF binding proteins (IGFBP), immunoglobulins, and acute phase proteins. The expression of mRNA associated with both the somatotropic axis and gluconeogenic enzymes was measured in the liver on day 60. Intensive feeding improved MR intake and growth in ADLIB without influencing concentrate intake. Carcass weight, perirenal fat, and muscle mass were greater in ADLIB. Plasma concentrations of glucose, triglycerides, insulin, and IGF-I were greater, whereas plasma concentrations of β-hydroxybutyrate, total protein, albumin, urea, IGFBP-2 and -4, and fibrinogen were lower at distinct time points in ADLIB. The hepatic mRNA expression of cytosolic phosphoenolpyruvate carboxykinase was greater in ADLIB. Most metabolic and endocrine differences occurred during the MR feeding period, but a slightly greater concentrate intake was associated with increased plasma IGF-I and insulin at the end of the study. The immune and health status of the calves were not affected by MR feeding. However, increased plasma fibrinogen in the RES group suggested differences in the acute phase response.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Feed Intake and Growth Performance.
Colostrum and milk replacer (MR) (A) and concentrate intake (B), total metabolizable energy (ME) intake, body weight (D), and average daily gain (E) in calves fed MR either ad libitum (ADLIB, black square, straight line) or restrictively (RES, white circle, dashed line) for the first five weeks of life. MR intake in ADLIB was gradually reduced during weeks 6 and 7 to amounts fed in RES. The data are presented as the least squares means ± standard error. Trend between groups P < 0.1; *different between groups P < 0.05; **different between groups P < 0.01; and ***different between groups P < 0.001.
Fig 2
Fig 2. Metabolic Status in Blood Plasma.
The plasma concentrations of glucose (A), lactate (B), beta-hydroxybutyrate (BHB; C), non-esterified fatty acids (NEFA; D), triglycerides (E), and cholesterol (F) in calves fed milk replacer (MR) either ad libitum (ADLIB, black square, straight line) or restrictively (RES, white circle, dashed line) for the first five weeks of life. MR intake in ADLIB was gradually reduced during weeks 6 and 7 to amounts fed in RES. The data are presented as the least squares means ± standard error. Trend between groups P < 0.1, *different between groups P < 0.05, **different between groups P < 0.01, and ***different between groups P < 0.001.
Fig 3
Fig 3. Endocrine Status in Blood Plasma.
The plasma concentrations of insulin (A), insulin-like growth factor 1 (IGF-I; B), and IGF-binding proteins (IGFBP)-2 (C), -3 (D), and -4 (E) in calves fed milk replacer (MR) either ad libitum (ADLIB, black square, straight line) or restrictively (RES, white circle, dashed line) for the first five weeks of life. MR intake in ADLIB was gradually reduced during weeks 6 and 7 to amounts fed in RES. The data are presented as the least squares means ± standard error. Trend between between groups P < 0.1, *different between groups P < 0.05, **different between groups P < 0.01, and ***different between groups P < 0.001.
Fig 4
Fig 4. Total Protein and Immune Status in Blood Plasma.
Plasma concentrations of total protein (A) and immunoglobulins (Ig) G1 (B), IgG2 (C), and IgM (D) in calves fed milk replacer (MR) either ad libitum (ADLIB, black square, straight line) or restrictively (RES, white circle, dashed line) for the first five weeks of life. MR intake in ADLIB was gradually reduced during weeks 6 and 7 to amounts fed in RES. The data are presented as the least squares means ± standard error. *Different between groups P < 0.05.
Fig 5
Fig 5. Inflammatory Status and Urea in Blood Plasma.
The plasma concentrations of albumin (A), urea (B), and fibrinogen (C) in calves fed milk replacer (MR) either ad libitum (ADLIB, black square, straight line) or restrictively (RES, white circle, dashed line) for the first five weeks of life. MR intake in ADLIB was gradually reduced during weeks 6 and 7 to amounts fed in RES. The data are presented as the least squares means ± standard error. Trend between between groups P < 0.1, *different between groups P < 0.05, and ***different between groups P < 0.001.

References

    1. Gulliksen SM, Lie KI, Loken T, Osteras O. Calf mortality in Norwegian dairy herds. J Dairy Sci. 2009; 92: 2782–2795. 10.3168/jds.2008-1807 - DOI - PubMed
    1. Mee JF. Newborn dairy calf management. Vet Clin North Am Food Anim Pract. 2008; 24: 1–17. 10.1016/j.cvfa.2007.10.002 - DOI - PubMed
    1. NAHMS (National Animal Health Monitoring System). Dairy 2011: Dairy heifer raiser. USDA:APHIS:VS USDA, Ft Collins, CO Accessed Nov 19, 2015. 2011.
    1. Svensson C, Linder A, Olsson SO. Mortality in Swedish dairy calves and replacement heifers. J Dairy Sci. 2006; 89: 4769–4777. 10.3168/jds.S0022-0302(06)72526-7 - DOI - PubMed
    1. Bartlett KS, McKeith FK, VandeHaar MJ, Dahl GE, Drackley JK. Growth and body composition of dairy calves fed milk replacers containing different amounts of protein at two feeding rates. J Anim Sci. 2006; 84: 1454–1467. 84/6/1454. - PubMed

MeSH terms

LinkOut - more resources